Almaral
Overview
Almaral is a Finnish venture capital firm specializing in early-stage investments in the biotechnology and life sciences sectors across Europe. The firm offers not only funding but also comprehensive support, including risk management advice, long-term strategy development, budgeting, operational function setup, legal support, and assistance with early-stage sales and marketing functions. This holistic approach aims to guide startups through the challenges of commercialization and international expansion. The firm's investment criteria include a focus on biotechnology and life sciences startups located in Europe, with investment needs ranging from €0.5 to €1 million. Almaral seeks companies with strong teams capable of executing their business plans and expects valuations that align with the company's development stage. A board position is typically anticipated, and the firm emphasizes responsible investing by adhering to Environmental, Social, and Governance (ESG) principles. Almaral's portfolio includes several success stories, such as Fepod, Genomill, and Marginum. These companies have praised Almaral for its comprehensive solutions, straightforward approach, and transparency. The firm's team comprises experienced professionals with backgrounds in immunochemistry, life sciences, and business operations, all committed to supporting innovative companies in the biotechnology industry.
Get the full list of 54,000+ investors
Almaral and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Almaral
What sectors does Almaral invest in?
Almaral invests in Life Sciences and Biotechnology, and is based in Finland. Almaral is listed as a venture capital in the ConnectSafely investor database.
What stage does Almaral invest at?
Almaral backs companies at Seed and Early Stage, writing cheques of 500K - 1M.
Which regions does Almaral invest in?
Almaral invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
Who are the partners at Almaral?
Team members listed for Almaral include Maria Severina (CEO, Angel investor) and Pekka Hildén (Partner).
How do I contact Almaral?
Almaral's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
